Cassie K. Chou, Ph.D.
Affiliations: | 2012 | Immunology | University of Washington, Seattle, Seattle, WA |
Area:
Immunology, Cell Biology, OncologyGoogle:
"Cassie Chou"Parents
Sign in to add mentorPhilip D Greenberg | grad student | 2012 | University of Washington | |
(Targeting a self/tumor antigen expressed in the prostate for adoptive T cell immunotherapy of prostate cancer.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Hirayama AV, Chou CK, Miyazaki T, et al. (2022) A novel polymer-conjugated human IL-15 improves efficacy of CD19-targeted CAR-T cell immunotherapy. Blood Advances |
Yang R, Sun L, Li CF, et al. (2021) Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy. Nature Communications. 12: 832 |
Gauthier J, Bezerra ED, Hirayama AV, et al. (2020) Factors associated with outcomes after a second CD19-targeted CAR T-cell infusion for refractory B cell malignancies. Blood |
Chou CK, Turtle CJ. (2020) Assessment and Management of Cytokine Release Syndrome and Neurotoxicity Following CD19 CAR-T Cell Therapy. Expert Opinion On Biological Therapy |
Chou CK, Turtle CJ. (2019) Insight into mechanisms associated with cytokine release syndrome and neurotoxicity after CD19 CAR-T cell immunotherapy. Bone Marrow Transplantation. 54: 780-784 |
Chou C, Fraessle S, Steinmetz R, et al. (2019) Combination of NKTR-255, a Polymer Conjugated Human IL-15, with CD19 CAR T Cell Immunotherapy in a Preclinical Lymphoma Model Blood. 134: 2866-2866 |
Chou CK, Schietinger A, Liggitt HD, et al. (2012) Cell-intrinsic abrogation of TGF-β signaling delays but does not prevent dysfunction of self/tumor-specific CD8 T cells in a murine model of autochthonous prostate cancer. Journal of Immunology (Baltimore, Md. : 1950). 189: 3936-46 |